The U.K. National Institute for Health and Care Excellence (NICE) has recommended two non-invasive tests, Endotest and EndoSure, for use in primary care to help identify endometriosis. While these tools aim to reduce the reliance on diagnostic laparoscopy—a surgical procedure currently required for confirmation—they are intended as supplementary aids rather than standalone diagnostic solutions while further real-world evidence is collected.
How the New Endometriosis Tests Function
Endotest and EndoSure represent different approaches to identifying the condition without surgery. According to Jila Senemar, M.D., FACOG, an OB/GYN and women’s health specialist, these tools target different biological and physiological indicators.
- Endotest: This test analyzes a saliva sample to identify specific microRNA patterns. Dr. Senemar notes that because these small regulatory molecules are involved in gene expression, they may provide a more disease-specific signature than standard inflammatory markers.
- EndoSure: This device measures electrical signals in the gut. Patients wear sensor pads on the abdomen while fasting; the test records gut activity over a 45-minute period to detect potential signs of endometriosis.
Did you know?
Endometriosis affects approximately 10% of reproductive-age women globally. Despite its prevalence, an inquiry by the U.K. government found that more than half of 10,000 surveyed patients visited their GP at least 10 times before receiving a formal diagnosis.
The Role of Evidence in Clinical Adoption
The NICE guidance mandates that these tests be used only when clinical examinations and imaging results are inconclusive or unavailable. The approval is tied to a three-year evidence-collection period. During this time, the manufacturers must organize data-gathering activities to verify how the tests perform in routine clinical practice.
Dr. Senemar emphasizes the importance of this phase, noting that diagnostic tests often show higher accuracy in specialized populations than in the general public. “When you move that same test into a broader population where fewer women actually have the disease, positive predictive value generally falls and false-positive results become more common,” she explains.
Comparing Diagnostic Pathways
Historically, definitive diagnosis has required a diagnostic laparoscopy. This surgical procedure involves a general anesthetic and the insertion of a camera into the abdomen. While it remains the gold standard for confirmation, it is costly, invasive, and carries surgical risks. The introduction of non-invasive testing is intended to address these systemic barriers, though current guidance dictates that these tests should not replace standard clinical judgment.
Pro Tips for Managing Pelvic Pain
- Document everything: Keep a detailed log of your symptoms, including frequency, intensity, and how they impact your daily life.
- Advocate for a referral: If you suspect endometriosis, present your symptom log to your GP and request a referral to a specialist.
- Stay informed: Follow updates from health authorities regarding the availability and clinical evidence of new diagnostic tools.
Availability in the United States
For women in the U.S., these tests are not currently available for routine clinical use. Any new diagnostic tool must undergo regulatory review and establish insurance coverage before widespread adoption. While U.S. researchers are exploring alternatives—including a blood test that recently reported 95% accuracy in a study—the U.K. rollout serves as a significant indicator of global shifts in diagnostic technology.
Frequently Asked Questions
Can I request a saliva test for endometriosis today?
No. These tests are currently being rolled out under specific clinical guidance in the U.K. and are not yet available for general use in the U.S.
Do these tests replace the need for surgery?
Not yet. NICE recommends these tests be used alongside standard clinical practice to help inform next steps, but they are not currently considered standalone diagnostic tools.
Why is a three-year evidence period required?
Real-world data is necessary to determine how accurate these tests are when used on a wider population, beyond the specific groups included in initial clinical trials.
Have you experienced long delays in receiving a diagnosis? Share your thoughts in the comments below or subscribe to our newsletter for the latest updates on women’s health research.
Worth a look